AVI BioPharma, Inc.

AVI BioPharma, Inc.

AVI BioPharma, Inc. was founded in 1980 and is based in Corvallis, Oregon. AVI BioPharma, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutic products based on antisense and cancer immunotherapy technology. The company's products under various development stages comprise AVI-4658, a Phase I human clinical trial product to restore, prevent, or slow deterioration of muscle function; AVI-5038, a preclinical stage product to skip exon 50 and restore a range of associated mutations; AVI-5126, a Phase II clinical trial product for the treatment of cardiovascular restenosis; and AVI-6002 and AVI6003, which are in Phase I clinical trials to treat diseases caused by Dengue, Ebola, Marburg, and Junín viruses. It has strategic alliances with Chiron Corporation; Cook Group Incorporated; Ercole Biotech, Inc.; Eleos Inc.; Charley's Fund, Inc.; and the United States Department of Defense.

Contact Details

Office Address

AVI BioPharma, Inc.
3450 Monte Villa Parkway, Suite 101
Bothell, WA, USA 98021
Phone: (425) 354-5038


Chief Exec. Officer, Pres. & Principal Operating Officer

Dr. Leslie Hudson

Chief Financial Officer

Mr. J. David Boyle II

Business Reviews for AVI BioPharma, Inc.

Related Companies